BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36940423)

  • 1. CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
    Lozada ME; Zhang N; Jin W; Wongjarupong N; Yang JD; Voss MM; Prasai K; Amakye DO; Harmsen WS; Chaudhary S; Bathe OF; Borad MJ; Patel TC; Gores GJ; Therneau TM; Roberts LR
    Am J Gastroenterol; 2023 Dec; 118(12):2173-2183. PubMed ID: 36940423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
    Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
    J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand.
    Sa-Ngiamwibool P; Aphivatanasiri C; Sangkhamanon S; Intarawichian P; Kunprom W; Thanee M; Prajumwongs P; Loilome W; Khuntikeo N; Titapun A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Eurboonyanun K; Promsorn J; Wee A; Koonmee S
    HPB (Oxford); 2022 Nov; 24(11):1944-1956. PubMed ID: 35810105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Kamarajah SK
    J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
    Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
    Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new clinically based staging system for perihilar cholangiocarcinoma.
    Chaiteerakij R; Harmsen WS; Marrero CR; Aboelsoud MM; Ndzengue A; Kaiya J; Therneau TM; Sanchez W; Gores GJ; Roberts LR
    Am J Gastroenterol; 2014 Dec; 109(12):1881-90. PubMed ID: 25384902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
    Liao P; Cao L; Chen H; Pang SZ
    Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
    Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
    Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.
    Lamarca A; Santos-Laso A; Utpatel K; La Casta A; Stock S; Forner A; Adeva J; Folseraas T; Fabris L; Macias RIR; Krawczyk M; Krawczyk M; Cardinale V; Braconi C; Alvaro D; Evert M; Banales JM; Valle JW;
    Hepatology; 2021 Jun; 73(6):2311-2325. PubMed ID: 33073396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
    Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
    Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of web-based nomograms for predicting survival status in patients with intrahepatic cholangiocarcinoma depending on the surgical status: a SEER database analysis.
    Liu YG; Jiang ST; Zhang JW; Zhang L; Zhao HT; Sang XT; Lu X; Xu YY
    Sci Rep; 2024 Jan; 14(1):1568. PubMed ID: 38238494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
    Thakral N; Gonzalez T; Nano O; Shin SH; Samuels S; Hussein A
    BMC Gastroenterol; 2023 May; 23(1):151. PubMed ID: 37179301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal number of examined lymph nodes for accurate staging of intrahepatic cholangiocarcinoma: A multi-institutional analysis using the nodal staging score model.
    Zhang R; Zhang J; Chen C; Qiu Y; Wu H; Song T; He Y; Li J; Zhang D; Geng Z; Tang Z
    Eur J Surg Oncol; 2023 Aug; 49(8):1429-1435. PubMed ID: 37005204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials.
    Lamarca A; Ross P; Wasan HS; Hubner RA; McNamara MG; Lopes A; Manoharan P; Palmer D; Bridgewater J; Valle JW
    J Natl Cancer Inst; 2020 Feb; 112(2):200-210. PubMed ID: 31077311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
    Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
    Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Jansson H; Villard C; Nooijen LE; Ghorbani P; Erdmann JI; Sparrelid E
    Eur J Surg Oncol; 2023 Apr; 49(4):688-699. PubMed ID: 36710214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.